Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ADH1A | P07327 | 2/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114324 | 1.00 | MAPT (0.32) | MAPTADH1AADH1C | |
| SCHEMBL21114240 | 1.00 | MAPT (0.32) | MAPTADH1AADH1C | |
| SCHEMBL21114303 | 1.00 | MAPT (0.32) | MAPTADH1AADH1C | |
| SCHEMBL21114266 | 1.00 | MAPT (0.32) | MAPTADH1AADH1C | |
| SCHEMBL21114273 | 1.00 | MAPT (0.32) | MAPTADH1AADH1C | |
| SCHEMBL5927006 | 0.98 | MAPT (0.33) | MAPTADH1AADH1C | |
| SCHEMBL15009202 | 0.91 | — | — | |
| SCHEMBL1426551 | 0.81 | — | — | |
| SCHEMBL21114286 | 0.80 | MAPT (0.31) | MAPT | |
| SCHEMBL21114282 | 0.80 | MAPT (0.31) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-10793499-B2 | — | — | 2020-10-06 | — | — | US | disclosed |
| EP-3514193-A1 | POLYVALENT PHENOL COMPOUND AND METHOD OF PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | RB1, FHIT, H1-4 | MAPT 2084/4885ADH1A 646/4885ADH1C 467/4885 |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | RB1, FHIT, H1-4 | MAPT 2084/4885ADH1A 646/4885ADH1C 467/4885 |
| US-10793499-B2 | — | RB1, H1-4, TPD52L2 | MAPT 3038/4885ADH1A 817/4885ADH1C 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.